RecallHawk

SULFAMETHOXAZOLE AND TRIMETHOPRIM

CHARTWELL MOLECULES

Summary

FDA approved SULFAMETHOXAZOLE AND TRIMETHOPRIM by CHARTWELL MOLECULES. ANDA (Generic) approval (Labeling) on 2022-09-16. TABLET, ORAL.

Details

Source

Drug Approval

External ID

ANDA078060-20

Action Date

2022-09-16

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

SULFAMETHOXAZOLE AND TRIMETHOPRIM, TABLET, ORAL. Application: ANDA078060

Context & Analysis

CHARTWELL MOLECULES has 8 FDA actions in our database.

Frequently Asked Questions

How often does CHARTWELL MOLECULES have FDA actions?

CHARTWELL MOLECULES has 8 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA078060-20" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions